leadf
logo-loader
viewBioLargo, Inc.

BioLargo says BLEST subsidiary awarded contract to assist in the reconfiguration of Regenerative Thermal Oxidizer (RTO) systems at a large chemicals plant

The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue

Chemicals plant
The plant, owned by a global chemical company, produces phenolic resins, antioxidants and related synthetic organic products

BioLargo, Inc. (OTCQB:BLGO) has announced that its subsidiary BioLargo Engineering, Science & Technologies (BLEST) has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer (RTO) systems used at a large chemical manufacturing plant on the East Coast of the US.

The plant, owned by a global chemical company, produces phenolic resins, antioxidants and related synthetic organic products. The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue, BioLargo said in a statement.

READ: BioLargo sees 3Q revenue rise by 60% with business development efforts paying off

An RTO is a device that destroys unwanted organic air contaminants produced as a result of the phenolic resin production process. It is a highly energy-efficient technology that uses waste heat to eliminate organic air contaminants, and is a crucial piece of equipment for this chemical plant, according to BioLargo, the developer of sustainable technologies and a full-service environmental engineering company.

The plant is preparing to shut down an existing, older RTO and re-route the exhaust treated by that RTO to a newer, much larger and more efficient RTO. This will result in significant energy efficiency and cost savings improvements to the facility, it added.

The work to reconfigure these RTO systems is not trivial, requiring substantial engineering and design work to ensure it proceeds safely and efficiently. BLEST has been contracted to conduct the initial engineering work to assess the feasibility of the RTO reconfiguration project. BLEST engineers have significant experience engineering and designing RTO systems, with some of its engineers having designed multiple RTO systems for the facility.

BioLargo is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to "make life better". 

Contact the author at [email protected]

Quick facts: BioLargo, Inc.

Price: 0.14425 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $32.08 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo's water technologies closer to commercialization, reports record 3Q

BioLargo, Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive its 3Q financial results saw its revenue rise 26% year-over-year to a record $0.67 million. Calvert says the group is ramping up several of its water technologies to prepare for commercialization including the AOS and the AEC, which...

1 week, 5 days ago

2 min read